A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
一项多中心 I 期临床试验，旨在探索一线多模式标准治疗和联合免疫疗法对新诊断胶质母细胞瘤的疗效。
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaf079
Wen, Patrick Y; Manzanera, Andrea; Duault, Caroline; Gonzalez-Kozlova, Edgar; Lopez, Lenika; Grossman, Stuart A; Ye, Xiaobu; Fisher, Joy; Lee, Ian; Walbert, Tobias; Snyder, James; Brem, Steven; Desai, Arati; Bagley, Stephen J; Kakani, Chandana; Strowd, Roy; Tatter, Stephen; Laxton, Adrian; Lesser, Glenn; Amankulor, Nduka; Lieberman, Frank; Drappatz, Jan; Mantica, Megan; Triggs, Dan; Haymaker, Cara; Wistuba, Ignacio I; Al-Atrash, Gheath; Mendoza Perez, Julia; Futreal, Andrew; Little, Latasha D; Islam, M D Habibul; Duose, Dzifa; Jiang, Peixin; Reuben, Alexandre; Lawler, Sean E; Pichavant, Mina; Gentles, Andrew; Bendall, Sean; Kong, Alex; Camacho, Christine; Del Valle, Diane; Kim-Schulze, Seunghee; Gnjatic, Sacha; Sharon, Elad; Nowicki, M Oskar; Peruzzi, Pierpaolo; Lane, Doug; Aguilar-Cordova, Estuardo; Aguilar, Laura K; Nichols, Garrett; Dwyer, Jessica; Tak, Paul Peter; Maecker, Holden; Barone, Francesca; Chiocca, E Antonio
